Back to Search
DAVID MULLINS, MD RVT FACS
MD RVT FACS
Surgery Physician
NPI: 1700998473IndividualAccepts Medicare
Specialties, Licenses & Credentials
Trauma Surgery Physician
Surgery — Trauma Surgery
Code: 2086S0127X
19244(WV)
Vascular Surgery Physician
Surgery — Vascular Surgery
Code: 2086S0129X
0101239029(VA)19244(WV)
Surgery PhysicianPrimary
Surgery
Code: 208600000X
19244(WV)
CMS Specialties
PrimaryGENERAL SURGERY
Education
WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE
Class of 1996
Research & Publications (20)
Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior.
PMID 18923820·Psychopharmacology (Berl)·2009
7-preclinical
Evaluation of ELISA for imidacloprid detection in eastern hemlock (Tsuga canadensis) wood and needle tissues.
PMID 18924117·Pest Manag Sci·2009
8-other
In situ phase separation of NiAu alloy nanoparticles for preparing highly active Au/NiO CO oxidation catalysts.
PMID 19006163·Chemphyschem·2008
8-other
An interprofessional educational intervention on delirium for health care teams: providing opportunities to enhance collaboration.
PMID 19012146·J Interprof Care·2008
8-other
Back to school: recommendations to assist mentally ill, post-incarcerated youth return to school.
PMID 18786044·J Sch Health·2008
8-other
Discovery of novel orally active ureido NPY Y5 receptor antagonists.
PMID 18160282·Bioorg Med Chem Lett·2008
7-preclinical
Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
PMID 18976648·Eur J Pharmacol·2008
7-preclinical
Regulation of neuropeptide Y Y1 receptors by testosterone in vascular smooth muscle cells in rat testis.
PMID 18535365·Neuroendocrinology·2008
7-preclinical
CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions.
PMID 17893230·Carcinogenesis·2007
8-other
Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression.
PMID 17291571·Pharmacol Biochem Behav·2007
4-observational
Immunity to melanoma antigens: from self-tolerance to immunotherapy.
PMID 16730266·Adv Immunol·2006
6-review
Rh-promoted methanol decomposition on cerium oxide thin films.
PMID 16898756·J Phys Chem B·2006
8-other
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.
PMID 16648140·J Biol Chem·2006
8-other
Limited infiltration of exogenous dendritic cells and naive T cells restricts immune responses in peripheral lymph nodes.
PMID 16585543·J Immunol·2006
7-preclinical
Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity.
PMID 16610810·J Med Chem·2006
4-observational
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma.
PMID 15905528·J Immunol·2005
5-case
AKT activation and response to interferon-beta in human cancer cells.
PMID 15970687·Cancer Biol Ther·2005
8-other
CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma.
PMID 16255782·BMC Cancer·2005
8-other
Preparation and comparison of supported gold nanocatalysts on anatase, brookite, rutile, and P25 polymorphs of TiO2 for catalytic oxidation of CO.
PMID 16852296·J Phys Chem B·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 201 12TH ST EXTENSION
PRINCETON, WV 24740 - Phone
- (304) 425-1852
Quick Facts
- NPI
- 1700998473
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile